MARC details
| 000 -LEADER |
| fixed length control field |
06068cam a2200505Ii 4500 |
| 001 - CONTROL NUMBER |
| control field |
ocn982092820 |
| 003 - CONTROL NUMBER IDENTIFIER |
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
| control field |
20251028093429.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
170408s2017 nyua b 001 0 eng d |
| 035 ## - SYSTEM CONTROL NUMBER |
| System control number |
(Sirsi) i9781682174555 |
| 040 ## - CATALOGING SOURCE |
| Original cataloging agency |
BTCTA |
| Language of cataloging |
eng |
| Description conventions |
rda |
| Transcribing agency |
BTCTA |
| Modifying agency |
YDX |
| -- |
XOT |
| -- |
KSU |
| -- |
LHA |
| -- |
R2A |
| -- |
WUT |
| -- |
SLV |
| -- |
SOI |
| -- |
NKM |
| -- |
CPT |
| -- |
LMR |
| -- |
WHCCD |
| -- |
SGB |
| -- |
JYJ |
| -- |
DON |
| -- |
FSA |
| -- |
OCLCF |
| -- |
SEO |
| -- |
OCLCA |
| -- |
Z45 |
| -- |
OWK |
| -- |
PZR |
| -- |
VF$ |
| 019 ## - |
| -- |
982098618 |
| -- |
982150033 |
| -- |
982231071 |
| -- |
982335251 |
| -- |
982391807 |
| -- |
982553690 |
| -- |
1008758603 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9781682174555 |
| Qualifying information |
(v. 89, no. 5) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
1682174557 |
| Qualifying information |
(v. 89, no. 5) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9781682174500 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
1682174506 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
9781682174548 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
1682174549 |
| 035 ## - SYSTEM CONTROL NUMBER |
| System control number |
(OCoLC)982092820 |
| Canceled/invalid control number |
(OCoLC)982098618 |
| -- |
(OCoLC)982150033 |
| -- |
(OCoLC)982231071 |
| -- |
(OCoLC)982335251 |
| -- |
(OCoLC)982391807 |
| -- |
(OCoLC)982553690 |
| -- |
(OCoLC)1008758603 |
| 043 ## - GEOGRAPHIC AREA CODE |
| Geographic area code |
n-us--- |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
| Classification number |
RM 146.5 |
| Item number |
.P74 2017 |
| 049 ## - LOCAL HOLDINGS (OCLC) |
| Holding library |
VF$A |
| 245 00 - TITLE STATEMENT |
| Title |
Prescription drug abuse / |
| Statement of responsibility, etc. |
compiled by H. W. Wilson, a division of EBSCO Information Services. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
| Place of production, publication, distribution, manufacture |
Amenia, NY : |
| Name of producer, publisher, distributor, manufacturer |
Grey House Publishing, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2017. |
| 300 ## - PHYSICAL DESCRIPTION |
| Extent |
xiv, 215 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
26 cm. |
| 336 ## - CONTENT TYPE |
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
| Media type term |
unmediated |
| Media type code |
n |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
| Carrier type term |
volume |
| Carrier type code |
nc |
| Source |
rdacarrier |
| 490 1# - SERIES STATEMENT |
| Series statement |
The reference shelf ; |
| Volume/sequential designation |
volume 89, number 5 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
| Bibliography, etc. note |
Includes bibliographical references (pages 207-210) and index. |
| 505 00 - FORMATTED CONTENTS NOTE |
| Miscellaneous information |
1: Pain and anxiety in America -- |
| Title |
National disorder: treating chronic conditions -- |
| -- |
Taking on the scourge of opioids / |
| Statement of responsibility |
Sally Satel -- |
| Title |
How prescription-drug abuse unleashed a heroin epidemic / |
| Statement of responsibility |
Kevin D. Williamson -- |
| Title |
The truth about prescription pills: one writer's story of anxiety and addiction / |
| Statement of responsibility |
Kelley McMillan -- |
| Title |
Almost half of all opioid misuse starts with a friend or family member's prescription / |
| Statement of responsibility |
Roni Dengler -- |
| Title |
Yes, benzos are bad for you / |
| Statement of responsibility |
Allen Frances -- |
| Title |
Casualties of the VA / |
| Statement of responsibility |
David French -- |
| Title |
War on prescription drugs: what if you depend on opioids to live a decent life? / |
| Statement of responsibility |
S.E. Smith. |
| 505 00 - FORMATTED CONTENTS NOTE |
| Miscellaneous information |
2: Drugs for young and old -- |
| Title |
Spectrum of risk -- |
| -- |
Prescription drug abuse among older adults is harder to detect / |
| Statement of responsibility |
Constance Gustke -- |
| Title |
Old and overmedicated: the real drug problem in nursing homes / |
| Statement of responsibility |
Ina Jaffe and Robert Benincasa -- |
| Title |
Fatal friendships: what happens when women share drugs on Facebook / |
| Statement of responsibility |
Jill DiDonato -- |
| Title |
College students aren't the only ones abusing Adderall / |
| Statement of responsibility |
Emma Pierson -- |
| Title |
Smack epidemic / |
| Statement of responsibility |
L. Jon Wertheim -- |
| Title |
US child opioid overdoses increased over past two decades, research finds / |
| Statement of responsibility |
Jessica Glenza -- |
| Title |
The hefty price of "study drug" misuse on college campuses / |
| Statement of responsibility |
Linda Begdache -- |
| Title |
Risky alone, deadly together / |
| Statement of responsibility |
Kimberly Kindy and Dan Keating. |
| 505 00 - FORMATTED CONTENTS NOTE |
| Miscellaneous information |
3: Doctors, big pharma and the gateway to abuse -- |
| Title |
The prescription drug business -- |
| -- |
The selling of attention deficit disorder / |
| Statement of responsibility |
Alan Schwarz -- |
| Title |
When the mailman unwittingly becomes a drug dealer / |
| Statement of responsibility |
Arian Campo-Flores and Jon Kamp -- |
| Title |
Alison's story: how $750,000 in drug "treatment" destroyed her life / |
| Statement of responsibility |
Warren Richey -- |
| Title |
Drug-company payments mirror doctors' brand-name prescribing / |
| Statement of responsibility |
Charles Ornstein, Ryann Grochowski Jones, and Mike Tigas -- |
| Title |
Opioid Rx abuse probe sees a record 31 doctors hit with sanctions in New Jersey / |
| Statement of responsibility |
Elizabeth Llorente. |
| 505 00 - FORMATTED CONTENTS NOTE |
| Miscellaneous information |
4: A search for solutions - treatment -- |
| Title |
Treatment and wellness -- |
| -- |
A primary care doctor delves into the opioid epidemic / |
| Statement of responsibility |
Monique Tello -- |
| Title |
The doctors who started the opioid epidemic / |
| Statement of responsibility |
Paul A. Offit -- Can we curb the opioid abuse epidemic by rethinking chronic pain? / |
| -- |
Richard Gunderman -- |
| Title |
The painkillers that could end the opioid crisis / |
| Statement of responsibility |
Adam Piore -- |
| Title |
How medical marijuana could help end the opioid epidemic / |
| Statement of responsibility |
Eric Killelea -- |
| Title |
What's really causing the prescription drug crisis? / |
| Statement of responsibility |
Johann Hari -- |
| Title |
After medical marijuana legalized, Medicare prescriptions drop for many drugs / |
| Statement of responsibility |
Shefali Luthra. |
| 505 00 - FORMATTED CONTENTS NOTE |
| Miscellaneous information |
5: A search for solutions - policy -- |
| Title |
The policy approach: restricting supply and legalizing treatment -- |
| -- |
Researchers use black-market drug website to gauge public health / |
| Statement of responsibility |
Felice J. Freyer -- |
| Title |
Are pharmaceutical companies to blame for the opioid epidemic? / |
| Statement of responsibility |
Alana Semuels -- |
| Title |
Ohio sues five drugmakers, saying they fueled opioid crisis / |
| Statement of responsibility |
Jeanne Whalen -- |
| Title |
Congress probes West Virginia opioid shipments / |
| Statement of responsibility |
Eric Eyre -- |
| Title |
States require opioid prescribers to check for "doctor shopping" / |
| Statement of responsibility |
Christine Vestal. |
| 520 ## - SUMMARY, ETC. |
| Summary, etc. |
In the modern world, physicians prescribe a multitude of medications, most derived from natural substances, to treat various bodily and mental disorders and some of the substances used also have a pleasurable neurological effect, creating a sense of euphoria, a tranquilizing effect, or intensifying alertness and focus. Over time, drug addiction and abuse has become a social justice and public health concern around the world. Governments have responded to addiction and drug abuse epidemics by banning the use of certain substances, but such efforts are not very efficacious and, instead, tend to result in the birth of black markets and criminal underworld industries involved in the production and distribution of illicit substances. In the 2010s, the drug crisis du jour in the United States involves the misuse and abuse of prescription drugs, substances developed as medications that have an intoxicating effect and so are also sought and used by individuals for recreation or to self-medicate. Because the supply of drugs cannot be completely eliminated without placing patients at risk, legislators, public health experts, and others working on the issue must struggle to balance the needs of patients with the effort to stem the tide of abuse. - Publisher/Preface |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Medication abuse |
| Geographic subdivision |
United States. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Opioid abuse |
| Geographic subdivision |
United States. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
Drug abuse |
| Geographic subdivision |
United States. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
| Corporate name or jurisdiction name as entry element |
H.W. Wilson Company |
| Relator term |
compiler. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
| Corporate name or jurisdiction name as entry element |
Grey House Publishing, Inc. |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
| Uniform title |
Reference shelf ; |
| Volume/sequential designation |
v. 89, no. 5. |
| 994 ## - |
| -- |
C0 |
| -- |
VF$ |